Over the last century the burden of infectious, or communicable, diseases has dramatically reduced in the Australian population,1 and until the COVID-19 pandemic, infectious diseases constituted 2% of the total disease burden.2 The COVID-19 pandemic has had broad and long-lasting consequences on health and healthcare delivery in Australia, not only on those directly affected by the disease. Prior to COVID-19, influenza was the most common vaccine-preventable disease in Australia, accounting for the most notifications.1 Lower respiratory tract infections comprise the sixth leading cause of total disease burden for children aged under five, while influenza and pertussis had the highest notification rates among young people aged 15–29.1,2
The low incidence of vaccine-preventable diseases in Australia is testament to the successful public health intervention of the National Immunisation Program of which general practice is the major site of immunisation.3 Part of this program is to provide catch-up immunisation for all people aged less than 20 years and for adult refugees and humanitarian entrants.4,5 Haemophilus influenzae type b (Hib) was the most common serious bacterial infection in young children in Australia; however, since the introduction of the Hib vaccine, invasive Hib disease notification rates have decreased by more than 95% in Aboriginal and Torres Strait Islander children aged under 5 years.6
General practice is involved in the surveillance, diagnosis and reporting of infectious diseases, including blood-borne viruses (BBVs) and sexually transmissible infections (STIs).7,8 This is vital in the prevention and control of infection.9 The most prevalent BBVs include human immunodeficiency virus (HIV), hepatitis B, and hepatitis C.10 Human T-cell lymphotropic virus–1 is known to cause chronic kidney disease and is more prevalent in Aboriginal and Torres Strait Islander peoples in Central Australia.11
Priority population groups that require additional support to prevent, manage and treat BBVs include people living with chronic BBVs, people who inject drugs, Aboriginal and Torres Strait Islander peoples, people from culturally and linguistically diverse backgrounds, people involved in the justice system, men who have sex with men and people engaged in sex work.10 Notifications of STIs including chlamydia, gonorrhoea and syphilis have increased in recent years, particularly among rural and remote Australians, Aboriginal and Torres Strait Islander peoples and non-Indigenous males in metropolitan settings.1
Part of a GP’s role is the control and management of infectious disease, including the prevention of acute rheumatic fever and rheumatic heart disease, where 89% of all cases are in Aboriginal and Torres Strait Islander peoples.12 There has been a continuing gradual decline in the prescription and use of antimicrobials, however, antimicrobial resistance continues to be a significant challenge.13 In 2019, more than 10 million people had at least one antimicrobial dispensed; this is significantly higher than other comparable countries.13 During the 2020 COVID-19 pandemic, there was a 22–49% decrease in dispensing of antimicrobials which suggests decreased seasonal respiratory infections because of increased public health infection control measures.13
Infection prevention and control is critical in general practice.14,15 Approximately 165,000 healthcare-associated infections occur every year in Australia.16 GPs and general practices have an important leadership role in preventing and managing infections like COVID-19, influenza and hepatitis in healthcare settings.15 The appropriate use of skin cleansers has been shown to have a role in reducing the incidence of healthcare-associated infections.8 Equally important is the safety of all clinical staff. Ensuring that all members of the practice team are safe, competently trained and aware of their role and responsibilities in relation to prevention and control of cross-infection and transmission of diseases is essential.16